Lineage Cell Therapeutics Inc (NYSE American:LCTX)

1.42
BATS BZX Real-Time Price
As of 10:30am ET
 +0.03 / +2.16%
Today’s Change
1.02
Today|||52-Week Range
2.71
-42.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues7.0M5.9M3.5M1.4M
 
 
 
 
 
Cost of Goods Sold1.1M358.0K168.0K302.0K
 
 
 
 
 
Depreciation And Amortization6.3M4.8M3.3M3.3M
 
 
 
 
 
 
Operating ExpensesGross Income-405.0K808.0K-6.0K-2.2M
 
 
 
 
 
General Expenses65.4M59.8M40.7M42.4M
 
 
 
 
 
Research And Development37.3M32.5M21.7M18.8M
 
 
 
 
 
Total Operating Expenses72.8M64.9M44.1M46.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-65.8M-59.0M-40.7M-44.6M
 
 
 
 
 
Extraordinary Credit0.000.0017.7M78.5M
 
 
 
Extraordinary Charge0.000.00-2.8M-87.3M
 
 
 
Pre-Tax Equity Earnings-35.0K29.7M----
 
 
 
Interest Expense On Debt465.0K747.0K692.0K--
 
 
 
 
Other Expenses3.5M48.6M3.2M5.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-62.7M18.6M-23.3M-47.1M
 
 
 
 
 
Income Taxes-4.5M0.000.00-346.0K
 
 
 
Minority Interest-11.1M-15.0M-3.3M-794.0K
 
 
 
 
 
Preferred Dividend-415.0K0.000.000.00
 
 
Net Income-47.0M33.6M-20.0M-46.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS79.7M97.3M114.5M126.9M
 
 
 
 
 
Shares To Calculate EPS Diluted79.7M99.6M114.5M126.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.59$0.34-$0.17-$0.36
 
 
 
 
 
EPS Diluted-$0.59$0.34-$0.17-$0.36